首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical Cancer Research

Clinical Cancer Research杂志,由American Association for Cancer Research Inc.出版,于1995年创刊,Semimonthly,出版语言English,ISSN:1078-0432,E-ISSN:1557-3265。

投稿咨询
Clinical Cancer Research
Clinical Cancer Research
Clinical Cancer Research
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
10.9
CiteScore
17.3
期刊收录
SCI、SCIE

Clinical Cancer Research(中文译名:《临床癌症研究》),ISSN:1078-0432,EISSN:1557-3265,是American Association for Cancer Research Inc.出版的国际性学术期刊,创刊于1995年,以Semimonthly形式稳定发行,2026年总发文量约457篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达10.9,2025年期刊CiteScore为17.3,2025年期刊自引率约1.8%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Clinical Cancer Research长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约2.1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Canada、CHINA MAINLAND、GERMANY (FED REP GER)、Spain、France等为核心发文国家与地区;HARVARD UNIVERSITYUNIVERSITY OF TEXAS SYSTEM、MEMORIAL SLOAN KETTERING CANCER CENTER、DANA-FARBER CANCER INSTITUTE、UNIVERSITY OF CALIFORNIA SYSTEM、MASSACHUSETTS GENERAL HOSPITAL、UNIVERSITY OF PENNSYLVANIA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
1区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
2区
是 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
1区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 33 / 333

90.2

学科:ONCOLOGY SCIE Q1 25 / 333

92.64

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 29 / 328

91.3

学科:ONCOLOGY SCIE Q1 22 / 328

93.45


中国学者近期发文

1
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Tria

Author:Xue, Liqiong; Han, Yaqian; Zhang, Qingyuan; Li, Xia; Fang, Meiyu; Zhong, Laiping; Wang, Siyang; Liu, Yanyan; Zhang, Songnan; Li, Zhiming; Guo, Ye

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 8, pp. 1445-1453. DOI: 10.1158/1078-0432.CCR-25-3930

2
Noninvasive Imaging Assessment of Tertiary Lymphoid Structures and Immunotherapy Response in Gastric Cancer: A Multicenter Stud

Author:Sun, Zepang; Li, Zhenhui; Ahmad, M. Usman; Zhu, Yun; Zhou, Zixia; Zhou, Kangneng; Wu, Lin; Chen, Chuanli; Yuan, Qingyu; Zhang, Taojun; Chen, Yan; Xie, Jingjing; Feng, Wanying; Xu, Yikai; Xiong, Wenjun; Wang, Wei; Li, Guoxin; Jiang, Yuming

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 8, pp. 1486-1498. DOI: 10.1158/1078-0432.CCR-25-3669

3
Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherap

Author:Shen, Yu; Wei, Mingtian; He, Yazhou; Yang, Tinghan; Deng, Xiangbing; Wu, Qingbin; Chen, Haining; Fan, Rui; Liu, Yiqian; Li, Qingyun; Li, Feifei; Gu, Xiafei; Lu, Zijian; Qiu, Meng; Meng, Wenjian; Jiang, Dan; Wang, Ziqiang

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1293-1301. DOI: 10.1158/1078-0432.CCR-25-3774

4
Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classificatio

Author:Qu, Shanqiang; Pan, Qiuming; Zhang, Xin; Wang, Junxi; Li, Hongrui; Huang, Yudi; Liao, Kuilin; Ye, Zhi; Ainiwan, Yilamujiang; Yi, Guozhong; Li, Zhiyong; Liu, Junlu; Hou, Xiaomin; Xu, Haiyan; Chen, Zhuoyang; Mei, Fen; Liu, Tao; Zhang, Xi'an; Qi, Songtao; Huang, Guanglong

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1349-1361. DOI: 10.1158/1078-0432.CCR-25-2496

5
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-623

Author:Pfeil, Alexander J.; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S.; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P.; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C.; de Stanchina, Elisa; Febres-Aldana, Christopher A.; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1362-1375. DOI: 10.1158/1078-0432.CCR-25-2734

6
Clinical Significance for Risk Stratification of Papillary Thyroid Cancer by TUMORFISHER Circulating Tumor Cell Techniqu

Author:Jiang, Liehao; Li, Xuejie; Ma, Tianyi; Zeng, Pingping; Tan, Zhuo; Zheng, Chuanming; Xu, Jiajie; Zhang, Lizhuo; Guo, Yaweng; Liang, Juyong; Pan, Yan; Teng, Weidong; Tao, Zekai; He, Jiantong; Yu, Haolan; Wang, Jiafeng; Hu, Zhiyuan; Ge, Minghua

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1313-1324. DOI: 10.1158/1078-0432.CCR-25-2694

7
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortiu

Author:Waliany, Sarah; Cooper, Alissa J.; Liu, Stephen V.; Gautschi, Oliver; Rotow, Julia K.; Smith, Katherine Emilie Rhoades; Weber, Urs M.; Lee, Dae Ho; Loong, Herbert H. F.; Patel, Jyoti D.; Pennell, Nathan A.; Nagasaka, Misako; Patel, Shetal A.; Tan, Daniel S. W.; Solomon, Benjamin J.; Kim, Tae Min; Pall, Georg; Riess, Jonathan W.; Sun, Lova; Fruh, Martin; Uy, Natalie F.; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B.; Baik, Christina S.; Lai, Gillianne G. Y.; Ou, S. Ignatius; Cheung, Kingsley S. Y.; Patil, Tejas; Mansfield, Aaron S.; Weiler, Daniela; Yeap, Beow Y.; Wirth, Lori J.; Gainor, Justin F.; Drilon, Alexander; Lin, Jessica J

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1157-1168. DOI: 10.1158/1078-0432.CCR-25-4382

8
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinom

Author:Rischin, Danny; Hansen, Aaron R.; Cohen, Ezra E. W.; Tahara, Makoto; Harrington, Kevin J.; Haddad, Robert I.; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L.; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R.; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J.; Washburn, Michael L.; Phillips-jones, Amy; Russell, John; Roy-ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1087-1099. DOI: 10.1158/1078-0432.CCR-25-1197

9
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinom

Author:Pant, Shubham; Park, Joon Oh; Su, Wu-Chou; Loriot, Yohann; Carranza, Omar; Corassa, Marcelo; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Prenen, Hans; Folprecht, Gunnar; Winter, Helen; Dal Molin, Graziela Z.; Shen, Lin; Qian, Jiaqi; Liao, Huimin; Thomas, Shibu; Sweiti, Hussein; Triantos, Spyros; Feng, Yin-Hsun

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1136-1144. DOI: 10.1158/1078-0432.CCR-25-2264

10
Pyrotinib plus capecitabine with or withoutradiotherapyin patients with HER2-positive metastatic breast cancer and brain metastases: Amulticenter, retrospective-prospective, real-world study in China (Post-PERMEATE

Author:Niu, L.; Liang, X.; Wang, S.; Zhang, S.; Lv, Z.; Li, H.; Zhao, Y.; Yin, Y.; Song, Y.; Sun, G.; Zhao, B.; Cai, L.; Ouyang, Q.; Geng, C.; Yao, H.; Wu, X.; Chen, Z.; Jiang, Z.; Li, H.; Yan, M

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue , pp. -. DOI:


在线咨询

Clinical Cancer Research

国际简称:CLIN CANCER RES参考译名:临床癌症研究

年发文量:457 CiteScore:17.3 是否预警:否 Gold OA文章占比:36.57% 研究类文章占比:88.84%

杂志社联系方式:AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Clinical Cancer Research